VERTEX PHARMACEUTICALS INC / MA (VRTX) Operating income 2016–2025
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual operating income history from SEC filings — each fiscal year as reported.
$4.2BFY2025 · since FY2016: $9.9M → $4.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.2B | +1891.9% |
| FY2024 | -$232.9M | -106.1% |
| FY2023 | $3.8B | -11.0% |
| FY2022 | $4.3B | +54.8% |
| FY2021 | $2.8B | -2.6% |
| FY2020 | $2.9B | +138.5% |
| FY2019 | $1.2B | +88.5% |
| FY2018 | $635.1M | +415.4% |
| FY2017 | $123.2M | +1140.4% |
| FY2016 | $9.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice